Gianino Maria Michela, Galzerano Mario, Minniti Davide, Di Novi Cinzia, Martin Barbara, Davini Ottavio, Barbaro Silvana
Department of Public Health, University of Turin, Italy.
Int J Technol Assess Health Care. 2009 Jul;25(3):411-4. doi: 10.1017/S0266462309990043.
The aim of this study is to perform a comparative costs analysis of brachytherapy (BT) and radical retropubic prostatectomy (RRP) for clinically localized prostate cancer and to shed light on the difficulties of comparing their relative economic effectiveness.
A systematic literature review of costing studies available in the Medline, Embase, DARE, and INAHTA databases.
There is a lack of homogeneity among published studies in this field. Differences in the reported costs are related to different environments in which the two techniques (BT and RRP) are applied, and in particular due to the use of different methodology, cost items included, time frames, and different price levels in different settings.
Published studies of costing data of BT and RRP do not provide clear-cut evidence for a conclusion about which treatment may be more effective from an economic point of view.
本研究旨在对临床局限性前列腺癌的近距离放射治疗（BT）和耻骨后根治性前列腺切除术（RRP）进行成本比较分析，并阐明比较它们相对经济有效性的困难。
对Medline、Embase、DARE和INAHTA数据库中现有的成本研究进行系统的文献综述。
该领域已发表的研究缺乏同质性。报告成本的差异与应用这两种技术（BT和RRP）的不同环境有关，特别是由于使用了不同的方法、纳入的成本项目、时间框架以及不同环境中的不同价格水平。
已发表的BT和RRP成本数据研究并未提供明确证据，无法得出从经济角度看哪种治疗可能更有效的结论。
